Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lombardo

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Journal of Neuro-Oncology|June 7, 2005
Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastomaAnn M Maddrey, Jon A Bergeron, Elizabeth R Lombardo, et al.
Acta Neuropathologica|August 4, 2001
Development of muscle pathology in canine X-linked muscular dystrophy. II. Quantitative characterization of histopathological progression during postnatal skeletal muscle developmentF Cozzi, M Cerletti, G C Luvoni, et al.
Journal of Neuroimmunology|May 30, 2009
Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis modelNicole A Belmar, John R Lombardo, Debra T Chao, et al.
Veterinary Clinical Pathology|January 30, 2014
Comparative study of select biochemical markers in cerebrospinal fluid of healthy dogs before and after treatment with nutraceuticalsA Galan, B E Carletti, J Morgaz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2023
Brief Report: Changing Characteristics Among In-Hospital HIV Deaths: An 11-Year Retrospective Review of a Regional Hospital in South AfricaAlexandra R Lombardo, Joshua Materi, Giorgio Caturegli, et al.
The Journal of Biological Chemistry|April 6, 2007
Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligaseShuichan Xu, Mahan Abbasian, Palka Patel, et al.
Cancer Immunology, Immunotherapy : CII|August 9, 2011
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cellsStefanie J Mandl, Ryan B Rountree, Katie Dalpozzo, et al.
EMBO Reports|June 27, 2009
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligaseSamiksha Katiyar, Enbo Liu, Christine A Knutzen, et al.
Journal of Biomolecular Techniques : JBT|January 13, 2004
The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interactionD G Myszka, Y N Abdiche, F Arisaka, et al.
Cancer Research|June 15, 2011
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacyRyan B Rountree, Stefanie J Mandl, James M Nachtwey, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Journal of Neuro-Oncology|June 7, 2005
Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastomaAnn M Maddrey, Jon A Bergeron, Elizabeth R Lombardo, et al.
Acta Neuropathologica|August 4, 2001
Development of muscle pathology in canine X-linked muscular dystrophy. II. Quantitative characterization of histopathological progression during postnatal skeletal muscle developmentF Cozzi, M Cerletti, G C Luvoni, et al.
Journal of Neuroimmunology|May 30, 2009
Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis modelNicole A Belmar, John R Lombardo, Debra T Chao, et al.
Veterinary Clinical Pathology|January 30, 2014
Comparative study of select biochemical markers in cerebrospinal fluid of healthy dogs before and after treatment with nutraceuticalsA Galan, B E Carletti, J Morgaz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2023
Brief Report: Changing Characteristics Among In-Hospital HIV Deaths: An 11-Year Retrospective Review of a Regional Hospital in South AfricaAlexandra R Lombardo, Joshua Materi, Giorgio Caturegli, et al.
The Journal of Biological Chemistry|April 6, 2007
Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligaseShuichan Xu, Mahan Abbasian, Palka Patel, et al.
Cancer Immunology, Immunotherapy : CII|August 9, 2011
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cellsStefanie J Mandl, Ryan B Rountree, Katie Dalpozzo, et al.
EMBO Reports|June 27, 2009
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligaseSamiksha Katiyar, Enbo Liu, Christine A Knutzen, et al.
Journal of Biomolecular Techniques : JBT|January 13, 2004
The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interactionD G Myszka, Y N Abdiche, F Arisaka, et al.
Cancer Research|June 15, 2011
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacyRyan B Rountree, Stefanie J Mandl, James M Nachtwey, et al.
Pageof 9